APA (7th ed.) Citation

Vestermark, L. W., Holtved, E., Dahlrot, R., Brimnes, M. K., Svane, I. M., & Bastholt, L. (2008). A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: Lymphopenia correlates with response. Ecancermedicalscience, 2, 1. https://doi.org/10.3332/ecancer.2008.91

Chicago Style (17th ed.) Citation

Vestermark, L. W., E. Holtved, R. Dahlrot, M. K. Brimnes, I M. Svane, and L. Bastholt. "A Phase II Study of Thalidomide and Temozolomide in Patients with Brain Metastases from Malignant Melanoma: Lymphopenia Correlates with Response." Ecancermedicalscience 2 (2008): 1. https://doi.org/10.3332/ecancer.2008.91.

MLA (9th ed.) Citation

Vestermark, L. W., et al. "A Phase II Study of Thalidomide and Temozolomide in Patients with Brain Metastases from Malignant Melanoma: Lymphopenia Correlates with Response." Ecancermedicalscience, vol. 2, 2008, p. 1, https://doi.org/10.3332/ecancer.2008.91.